- Home
- All Stock List
- NSE
- Bal Pharma Ltd Share Price
103.04
-0.36 (-0.35%)
-
Underperforms Index
4.03%
Return (1Y)
Underperformed Nifty 50 by 3.45%
-
More Volatile
3.57%
Standard Deviation (1Y)
Higher than Nifty 50 by 2.63%
-
Not so consistent
4/12
Months
underperformed Nifty 50
-
AxisDirect View
No View
158
78
News & Announcements
-
Bal Pharma Ltd leads gainers in 'B' group
27 days ago
Chemcrux Enterprises Ltd, Maral Overseas Ltd, Growington Ventures India Ltd and Orchasp Ltd are among the other gainers in the BSE's 'B' group today, 03 April 2025.
Bal Pharma Ltd soared 20.00% to Rs 109.04 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.98 lakh shares were traded on the counter so far as against the average daily volumes of 5629 shares in the past one month.
Chemcrux Enterprises Ltd surged 19.99% to Rs 143.15. The stock was the second biggest gainer in 'B' group. On the BSE, 36065 shares were traded on the counter so far as against the average daily volumes of 13458 shares in the past one month.
Maral Overseas Ltd spiked 19.99% to Rs 75.34. The stock was the third biggest gainer in 'B' group. On the BSE, 21729 shares were traded on the counter so far as against the average daily volumes of 1866 shares in the past one month.
Growington Ventures India Ltd jumped 19.71% to Rs 3.28. The stock was the fourth biggest gainer in 'B' group. On the BSE, 12.2 lakh shares were traded on the counter so far as against the average daily volumes of 4.94 lakh shares in the past one month.
Orchasp Ltd exploded 15.41% to Rs 3.67. The stock was the fifth biggest gainer in 'B' group. On the BSE, 12.39 lakh shares were traded on the counter so far as against the average daily volumes of 2.02 lakh shares in the past one month.
Powered by Capital Market - Live News
-
Bal Pharma consolidated net profit declines 46.07% in the December 2024 quarter
14 - Feb - 2025 12:00 | 75 days ago
Net profit of Bal Pharma declined 46.07% to Rs 0.48 crore in the quarter ended December 2024 as against Rs 0.89 crore during the previous quarter ended December 2023. Sales declined 10.42% to Rs 73.15 crore in the quarter ended December 2024 as against Rs 81.66 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 73.15 81.66 -10 OPM % 10.59 9.54 - PBDT 3.25 4.23 -23 PBT 0.57 1.27 -55 NP 0.48 0.89 -46 Powered by Capital Market - Live News
-
Bal Pharma standalone net profit declines 7.94% in the December 2024 quarter
14 - Feb - 2025 12:00 | 75 days ago
Net profit of Bal Pharma declined 7.94% to Rs 1.16 crore in the quarter ended December 2024 as against Rs 1.26 crore during the previous quarter ended December 2023. Sales declined 10.55% to Rs 72.89 crore in the quarter ended December 2024 as against Rs 81.49 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 72.89 81.49 -11 OPM % 10.59 9.61 - PBDT 3.53 4.23 -17 PBT 1.20 1.68 -29 NP 1.16 1.26 -8 Powered by Capital Market - Live News
-
Bal Pharma consolidated net profit declines 46.07% in the December 2024 quarter
14 - Feb - 2025 12:00 | 75 days ago
Net profit of Bal Pharma declined 46.07% to Rs 0.48 crore in the quarter ended December 2024 as against Rs 0.89 crore during the previous quarter ended December 2023. Sales declined 10.42% to Rs 73.15 crore in the quarter ended December 2024 as against Rs 81.66 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 73.15 81.66 -10 OPM % 10.59 9.54 - PBDT 3.25 4.23 -23 PBT 0.57 1.27 -55 NP 0.48 0.89 -46 Powered by Capital Market - Live News
-
Bal Pharma standalone net profit declines 7.94% in the December 2024 quarter
14 - Feb - 2025 12:00 | 75 days ago
Net profit of Bal Pharma declined 7.94% to Rs 1.16 crore in the quarter ended December 2024 as against Rs 1.26 crore during the previous quarter ended December 2023. Sales declined 10.55% to Rs 72.89 crore in the quarter ended December 2024 as against Rs 81.49 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 72.89 81.49 -11 OPM % 10.59 9.61 - PBDT 3.53 4.23 -17 PBT 1.20 1.68 -29 NP 1.16 1.26 -8 Powered by Capital Market - Live News
-
Bal Pharma to hold board meeting
95 days ago
-
Bal Pharma Ltd leads gainers in 'B' group
27 days ago
Chemcrux Enterprises Ltd, Maral Overseas Ltd, Growington Ventures India Ltd and Orchasp Ltd are among the other gainers in the BSE's 'B' group today, 03 April 2025.
Bal Pharma Ltd soared 20.00% to Rs 109.04 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.98 lakh shares were traded on the counter so far as against the average daily volumes of 5629 shares in the past one month.
Chemcrux Enterprises Ltd surged 19.99% to Rs 143.15. The stock was the second biggest gainer in 'B' group. On the BSE, 36065 shares were traded on the counter so far as against the average daily volumes of 13458 shares in the past one month.
Maral Overseas Ltd spiked 19.99% to Rs 75.34. The stock was the third biggest gainer in 'B' group. On the BSE, 21729 shares were traded on the counter so far as against the average daily volumes of 1866 shares in the past one month.
Growington Ventures India Ltd jumped 19.71% to Rs 3.28. The stock was the fourth biggest gainer in 'B' group. On the BSE, 12.2 lakh shares were traded on the counter so far as against the average daily volumes of 4.94 lakh shares in the past one month.
Orchasp Ltd exploded 15.41% to Rs 3.67. The stock was the fifth biggest gainer in 'B' group. On the BSE, 12.39 lakh shares were traded on the counter so far as against the average daily volumes of 2.02 lakh shares in the past one month.
Powered by Capital Market - Live News
-
Bal Pharma consolidated net profit declines 46.07% in the December 2024 quarter
14 - Feb - 2025 12:00 | 75 days ago
Net profit of Bal Pharma declined 46.07% to Rs 0.48 crore in the quarter ended December 2024 as against Rs 0.89 crore during the previous quarter ended December 2023. Sales declined 10.42% to Rs 73.15 crore in the quarter ended December 2024 as against Rs 81.66 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 73.15 81.66 -10 OPM % 10.59 9.54 - PBDT 3.25 4.23 -23 PBT 0.57 1.27 -55 NP 0.48 0.89 -46 Powered by Capital Market - Live News
-
Bal Pharma standalone net profit declines 7.94% in the December 2024 quarter
14 - Feb - 2025 12:00 | 75 days ago
Net profit of Bal Pharma declined 7.94% to Rs 1.16 crore in the quarter ended December 2024 as against Rs 1.26 crore during the previous quarter ended December 2023. Sales declined 10.55% to Rs 72.89 crore in the quarter ended December 2024 as against Rs 81.49 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 72.89 81.49 -11 OPM % 10.59 9.61 - PBDT 3.53 4.23 -17 PBT 1.20 1.68 -29 NP 1.16 1.26 -8 Powered by Capital Market - Live News
-
Bal Pharma to hold board meeting
95 days ago
-
Bal Pharma Ltd leads gainers in 'B' group
27 days ago
Chemcrux Enterprises Ltd, Maral Overseas Ltd, Growington Ventures India Ltd and Orchasp Ltd are among the other gainers in the BSE's 'B' group today, 03 April 2025.
Bal Pharma Ltd soared 20.00% to Rs 109.04 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.98 lakh shares were traded on the counter so far as against the average daily volumes of 5629 shares in the past one month.
Chemcrux Enterprises Ltd surged 19.99% to Rs 143.15. The stock was the second biggest gainer in 'B' group. On the BSE, 36065 shares were traded on the counter so far as against the average daily volumes of 13458 shares in the past one month.
Maral Overseas Ltd spiked 19.99% to Rs 75.34. The stock was the third biggest gainer in 'B' group. On the BSE, 21729 shares were traded on the counter so far as against the average daily volumes of 1866 shares in the past one month.
Growington Ventures India Ltd jumped 19.71% to Rs 3.28. The stock was the fourth biggest gainer in 'B' group. On the BSE, 12.2 lakh shares were traded on the counter so far as against the average daily volumes of 4.94 lakh shares in the past one month.
Orchasp Ltd exploded 15.41% to Rs 3.67. The stock was the fifth biggest gainer in 'B' group. On the BSE, 12.39 lakh shares were traded on the counter so far as against the average daily volumes of 2.02 lakh shares in the past one month.
Powered by Capital Market - Live News
-
Bal Pharma consolidated net profit declines 46.07% in the December 2024 quarter
14 - Feb - 2025 12:00 | 75 days ago
Net profit of Bal Pharma declined 46.07% to Rs 0.48 crore in the quarter ended December 2024 as against Rs 0.89 crore during the previous quarter ended December 2023. Sales declined 10.42% to Rs 73.15 crore in the quarter ended December 2024 as against Rs 81.66 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 73.15 81.66 -10 OPM % 10.59 9.54 - PBDT 3.25 4.23 -23 PBT 0.57 1.27 -55 NP 0.48 0.89 -46 Powered by Capital Market - Live News
-
Bal Pharma standalone net profit declines 7.94% in the December 2024 quarter
14 - Feb - 2025 12:00 | 75 days ago
Net profit of Bal Pharma declined 7.94% to Rs 1.16 crore in the quarter ended December 2024 as against Rs 1.26 crore during the previous quarter ended December 2023. Sales declined 10.55% to Rs 72.89 crore in the quarter ended December 2024 as against Rs 81.49 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 72.89 81.49 -11 OPM % 10.59 9.61 - PBDT 3.53 4.23 -17 PBT 1.20 1.68 -29 NP 1.16 1.26 -8 Powered by Capital Market - Live News
-
Bal Pharma consolidated net profit declines 46.07% in the December 2024 quarter
14 - Feb - 2025 12:00 | 75 days ago
Net profit of Bal Pharma declined 46.07% to Rs 0.48 crore in the quarter ended December 2024 as against Rs 0.89 crore during the previous quarter ended December 2023. Sales declined 10.42% to Rs 73.15 crore in the quarter ended December 2024 as against Rs 81.66 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 73.15 81.66 -10 OPM % 10.59 9.54 - PBDT 3.25 4.23 -23 PBT 0.57 1.27 -55 NP 0.48 0.89 -46 Powered by Capital Market - Live News
-
Bal Pharma standalone net profit declines 7.94% in the December 2024 quarter
14 - Feb - 2025 12:00 | 75 days ago
Net profit of Bal Pharma declined 7.94% to Rs 1.16 crore in the quarter ended December 2024 as against Rs 1.26 crore during the previous quarter ended December 2023. Sales declined 10.55% to Rs 72.89 crore in the quarter ended December 2024 as against Rs 81.49 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 72.89 81.49 -11 OPM % 10.59 9.61 - PBDT 3.53 4.23 -17 PBT 1.20 1.68 -29 NP 1.16 1.26 -8 Powered by Capital Market - Live News
-
Bal Pharma to hold board meeting
95 days ago
Stock Trivia
FII shareholding in Bal Pharma Ltd has increased by 4.9% since past 1 Year
FII shareholding in Bal Pharma Ltd has increased by 4.9% since past 1 Year
FII shareholding in Bal Pharma Ltd has increased by 4.9% since past 1 Year
FII shareholding in Bal Pharma Ltd has increased by 4.9% since past 1 Year
FII shareholding in Bal Pharma Ltd has increased by 4.9% since past 1 Year
